GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Haoyuan Chemexpress Co Ltd (SHSE:688131) » Definitions » Forward PE Ratio

Shanghai Haoyuan Chemexpress Co (SHSE:688131) Forward PE Ratio : 33.17 (As of May. 15, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Haoyuan Chemexpress Co Forward PE Ratio?

Shanghai Haoyuan Chemexpress Co's Forward PE Ratio for today is 33.17.

Shanghai Haoyuan Chemexpress Co's PE Ratio without NRI for today is 21.65.

Shanghai Haoyuan Chemexpress Co's PE Ratio (TTM) for today is 33.08.


Shanghai Haoyuan Chemexpress Co Forward PE Ratio Historical Data

The historical data trend for Shanghai Haoyuan Chemexpress Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haoyuan Chemexpress Co Forward PE Ratio Chart

Shanghai Haoyuan Chemexpress Co Annual Data
Trend 2024-12
Forward PE Ratio
31.69

Shanghai Haoyuan Chemexpress Co Quarterly Data
2024-12 2025-03
Forward PE Ratio 31.69 34.52

Competitive Comparison of Shanghai Haoyuan Chemexpress Co's Forward PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Haoyuan Chemexpress Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haoyuan Chemexpress Co's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Haoyuan Chemexpress Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Haoyuan Chemexpress Co's Forward PE Ratio falls into.


;
;

Shanghai Haoyuan Chemexpress Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Shanghai Haoyuan Chemexpress Co  (SHSE:688131) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Shanghai Haoyuan Chemexpress Co Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Haoyuan Chemexpress Co's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haoyuan Chemexpress Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
Executives
Mei Kui Core technical personnel

Shanghai Haoyuan Chemexpress Co Headlines

No Headlines